Sedation in critically ill patients - Practical recommendations

被引:11
作者
Gravel, NR [1 ]
Searle, NR [1 ]
Sahab, PG [1 ]
Carrier, M [1 ]
机构
[1] Montreal Heart Inst, Dept Anaesthesia, Montreal, PQ H1T 1C8, Canada
关键词
D O I
10.2165/00023210-199911010-00002
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Provision of anxiolysis and analgesia in critically ill patients is mandatory to improve patient comfort without undue autonomic or haemodynamic adverse effects, The assessment of the level of sedation in the intensive care unit (ICU) by means of scoring systems is important because both undersedation and oversedation can be counterproductive, Scoring systems, such as the Ramsay Sedation Score or the Modified Observer's Assessment of Alertness/Sedation Scale, offer an accurate means of communicating clinical information and monitoring clinical progress, Understanding how the pharmacokinetic and pharmacodynamic profiles of sedative and analgesic agents are altered in critically ill patients is essential for administering effective care, Midazolam and lorazepam are commonly used to provide anxiolysis and amnesia, Although there are variations in morphine metabolism and/or excretion in certain disease states, it remains the opioid of choice for critically ill patients, Because of its unique pharmacokinetic properties, remifentanil may eventually prove to be an interesting alternative. Propofol possesses many characteristics of the ideal sedative agent: rapid onset of effect, easy titration, unaltered pharmacokinetics in hepatic and renal dysfunction, and rapid recovery after prolonged infusion. Conditions most likely encountered in the ICU are reviewed and practical recommendations are provided. Sedation in patients with multiple organ failure raises several interesting problems regarding distribution volumes, plasma protein binding, metabolic rate, tissue perfusion, drug excretion and requirement for prolonged sedation. Weaning from prolonged sedation can be difficult and may reveal drug dependency. The use of propofol can case the transition from long term benzodiazepine use. Patients with respiratory failure are a special group in whom propofol seems to have a favourable profile. Unless absolutely necessary, neuromuscular blocking agents should be avoided. If these agents must be used, it is incumbent to provide appropriate sedation and monitor the neuromuscular junction with a peripheral nerve stimulator. Opioid drugs should be used sparingly. Compared with other medical conditions, sedation post-cardiac surgery has received a lot of attention. Propofol or midazolam in association with morphine are effective and well tolerated. Both can be use for short term sedation without jeopardising early tracheal extubation.
引用
收藏
页码:9 / 22
页数:14
相关论文
共 61 条
[1]   COMPARISON OF PROPOFOL AND MIDAZOLAM FOR SEDATION IN CRITICALLY ILL PATIENTS [J].
AITKENHEAD, AR ;
WILLATTS, SM ;
PARK, GR ;
COLLINS, CH ;
LEDINGHAM, IM ;
PEPPERMAN, ML ;
COATES, PD ;
BODENHAM, AR ;
SMITH, MB ;
WALLACE, PGM .
LANCET, 1989, 2 (8665) :704-709
[2]   PHARMACOKINETICS OF LONG-TERM PROPOFOL INFUSION USED FOR SEDATION IN ICU PATIENTS [J].
ALBANESE, J ;
MARTIN, C ;
LACARELLE, B ;
SAUX, P ;
DURAND, A ;
GOUIN, F .
ANESTHESIOLOGY, 1990, 73 (02) :214-217
[3]  
ASHTON H, 1987, BRIT J ADDICT, V82, P665
[4]   BENZODIAZEPINES - CLINICAL-PHARMACOLOGY AND THERAPEUTIC USE [J].
BELLANTUONO, C ;
REGGI, V ;
TOGNONI, G ;
GARATTINI, S .
DRUGS, 1980, 19 (03) :195-219
[5]   POSTOPERATIVE INFECTIONS TRACED TO CONTAMINATION OF AN INTRAVENOUS ANESTHETIC, PROPOFOL [J].
BENNETT, SN ;
MCNEIL, MM ;
BLAND, LA ;
ARDUINO, MJ ;
VILLARINO, ME ;
PERROTTA, DM ;
BURWEN, DR ;
WELBEL, SF ;
PEGUES, DA ;
STROUD, L ;
ZEITZ, PS ;
JARVIS, WR .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (03) :147-154
[6]   SEDATION IN INTENSIVE-CARE - MORPHINE AND RENAL-FUNCTION [J].
BION, JF ;
LOGAN, BK ;
NEWMAN, PM ;
BRODIE, MJ ;
OLIVER, JS ;
AITCHISON, TC ;
LEDINGHAM, IM .
INTENSIVE CARE MEDICINE, 1986, 12 (05) :359-365
[7]   INTENSIVE MANAGEMENT OF SEVERE HEAD-INJURY [J].
BOREL, C ;
HANLEY, D ;
DIRINGER, MN ;
ROGERS, MC .
CHEST, 1990, 98 (01) :180-189
[8]  
BORGEAT A, 1994, ANESTHESIOLOGY, V80, P642
[9]   EFFECT OF NEUROTRAUMA ON HEPATIC DRUG CLEARANCE [J].
BOUCHER, BA ;
KUHL, DA ;
FABIAN, TC ;
ROBERTSON, JT .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 50 (05) :487-497
[10]   FLUMAZENIL - A REAPPRAISAL OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY AS A BENZODIAZEPINE ANTAGONIST [J].
BROGDEN, RN ;
GOA, KL .
DRUGS, 1991, 42 (06) :1061-1089